Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128621) titled 'Efficacy-Driven Extended Administration Intervals of Stapokibart for Chronic Rhinosinusitis with Nasal Polyps: A Multicenter Real-World Study' on July 23.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Eye & ENT hospital of Fudan University
Condition:
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-01
Target Sample Size: Stapokibart group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334059
Disclaimer: Curated by HT Syndication....